Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP956396.RAjUwDW5yzAZUcFsBeQRCUFkDeRUABGMYYZKztBghB4mY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP956396.RAjUwDW5yzAZUcFsBeQRCUFkDeRUABGMYYZKztBghB4mY130_assertion type Assertion NP956396.RAjUwDW5yzAZUcFsBeQRCUFkDeRUABGMYYZKztBghB4mY130_head.
- NP956396.RAjUwDW5yzAZUcFsBeQRCUFkDeRUABGMYYZKztBghB4mY130_assertion description "[A total of 209 consecutive patients with stage IV nonsquamous NSCLC with an EGFR (epidermal growth factor receptor) mutation (N = 39), KRAS (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutation (N = 49), ALK (anaplastic lymphoma receptor tyrosine kinase) gene rearrangement (N = 41), or wild-type for all 3 (triple negative, N = 80) were included.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP956396.RAjUwDW5yzAZUcFsBeQRCUFkDeRUABGMYYZKztBghB4mY130_provenance.
- NP956396.RAjUwDW5yzAZUcFsBeQRCUFkDeRUABGMYYZKztBghB4mY130_assertion evidence source_evidence_literature NP956396.RAjUwDW5yzAZUcFsBeQRCUFkDeRUABGMYYZKztBghB4mY130_provenance.
- NP956396.RAjUwDW5yzAZUcFsBeQRCUFkDeRUABGMYYZKztBghB4mY130_assertion SIO_000772 22282022 NP956396.RAjUwDW5yzAZUcFsBeQRCUFkDeRUABGMYYZKztBghB4mY130_provenance.
- NP956396.RAjUwDW5yzAZUcFsBeQRCUFkDeRUABGMYYZKztBghB4mY130_assertion wasDerivedFrom befree-2016 NP956396.RAjUwDW5yzAZUcFsBeQRCUFkDeRUABGMYYZKztBghB4mY130_provenance.
- NP956396.RAjUwDW5yzAZUcFsBeQRCUFkDeRUABGMYYZKztBghB4mY130_assertion wasGeneratedBy ECO_0000203 NP956396.RAjUwDW5yzAZUcFsBeQRCUFkDeRUABGMYYZKztBghB4mY130_provenance.